1. Home
  2. Blogs for January, 2021

Month: January 2021

AMB :- Opalesque Roundup: Hedge fund assets hit record $3.6tn after delivering best performance in more than a decade: hedge fund news, week 04

In the week ending January 22nd 2021, HFR reported that hedge fund industry capital surged to conclude a volatile 2020 as strong performance gains drove hedge fund assets globally, and in particular Equity Hedge strategi...Article

AMB :- Opalesque Exclusive: French quant house uses data to understand what the market practitioners think, not to understand the market itself

B. G., Opalesque Geneva: Quantology Capital Management is a Paris-based hedge fund and specialist of behavioural finance. Its motto is "No beliefs, only processes". It has emerged as one of the best absolute re...Article Link

Opalesque Roundup: Hedge fund assets hit record $3.6tn after delivering best performance in more than a decade: hedge fund news, week 04

In the week ending January 22nd 2021, HFR reported that hedge fund industry capital surged to conclude a volatile 2020 as strong performance gains drove hedge fund assets globally, and in particular Equity Hedge strategies,

Opalesque Exclusive: French quant house uses data to understand what the market practitioners think, not to understand the market itself

B. G., Opalesque Geneva: Quantology Capital Management is a Paris-based hedge fund and specialist of behavioural finance...Article Link

AMB :- Europe shatters annual record for VC investment attracting $49bn in 2020

Laxman Pai, Opalesque Asia: Europe beat its previous annual high of $41.9 billion in VC investment (2019), attracting $49 billion in VC investment in 2020, said a study. According to the KPMG Private Enterprise Venture

AMW :- Opalesque Roundup: Hedge fund assets hit record $3.6tn after delivering best performance in more than a decade: hedge fund news, week 04

In the week ending January 22nd 2021, HFR reported that hedge fund industry capital surged to conclude a volatile 2020 as strong performance gains drove hedge fund assets globally, and in particular Equity Hedge strategies,

Blue Horizon Ventures makes final close of first fund

The firm raised "well beyond" initial target of €183m

Gaia expands European operations with new German office

The new Berlin office will be headed by Robin Eric Haak, hired as general partner in the DACH and Nordics markets

Norway’s HitecVision in exclusive talks to buy Exxon’s UK assets

The talks are aimed at closing a deal by the end of the quarter, the energy-focused firm said

Alchemy rules out offer for UK estate agency group Countrywide

Decision brings to an end speculation that Countrywide could make renewed offer

LP Profile: IMCO

Investment Management Corporation of Ontario (IMCO) managing director Craig Ferguson talks to Eliza Punshi about accelerated deployment activity during the pandemic and the LP's plans to scale up its private equity allocation by 2025

HCAP Partners buys into clinical trial, commerical medicine patient finder 83bar

California-based private equity house HCAP Partners has backed 83bar, which helps to find and retain qualified individuals for clinical trials and commercial clients.

Partners Group becomes majority owner of TA, HGGC-backed Idera

Global private markets investment major Partners Group has upped its investment in IT professional software provider Idera to become the majority owner.

Elbrus holds first close on $260m for third fund – report

Russia and CIS-focused private equity firm Elbrus Capital has held a first close on $260m for its latest vehicle, Elbrus Capital Fund III, according to local press reports.

CVC in talks for Shiseidio personal care business, deal could reach $1.9bn

CVC Capital Partners is in talks to buy a suite of skincare and shampoo brands from Japanese cosmetics business Shiseido in a deal which could reportedly reach $1.9bn.

Spac demand to draw VCs to clean tech

Interest in taking clean technology companies public surged after a decade when few such companies reached public markets

Alta Life Sciences invests in Inbiomotion

Alta Life Sciences has led an investment round for Barcelona-based Inbiomotion, a biotech company specialising in diagnostics for breast cancer.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.